Cepheid Rectal Sample Validation Study

Status Completed

Clinical Trial Summary

The purpose of this study is to validate Xpert CT/NG for the detection of CT and GC in rectal samples as part of the PA DOH and CLIA requirements. The evaluation of samples obtained from the pharynx is exploratory and will provide new information on the frequency of pharyngeal infection due to CT and GC.

A secondary objective will be to evaluate the prevalence of Trichomonas vaginalis in vaginal and rectal samples using both the Xpert system and AC2 to assess whether women positive for this pathogen rectally usually or always have vaginal infection due to this pathogen.

The investigators hypothesis is that real-time PCR (polymerase chain reaction) amplification testing with the Cepheid Xpert CT/NG will have greater sensitivity than culture in detecting Neisseria gonorrhoeae in rectal samples. The investigators also hypothesize that Xpert CT/NG will be equivalent to the Gen-Probe APTIMA Combo2 (AC2) in detecting Chlamydia trachomatis and Neisseria gonorrhoeae in rectal samples.

Clinical Trial Description

Because of its high sensitivity and specificity, NAAT testing has largely replaced bacterial culture for the diagnosis of genital CT and GC in both males and females. NAAT assays have the greatest potential for detecting CT and GC in the rectum; however, no NAAT is currently cleared for use with extragenital specimens by the US Food and Drug Administration.

In order to comply with CLIA regulations, laboratories must perform in-house validations to use NAATs with rectal and pharyngeal specimens. There are multiple studies in the literature evaluating NAAT assays in diagnosing CT and GC in rectal and pharyngeal specimens using expanded reference standards, which includes positive culture result and secondary confirmatory NAAT assays. The proposed validation study is intended to provide data to support the use of NAAT for rectal and pharyngeal specimens. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02099760
Study type	Observational
Source	University of Pittsburgh
Contact
Status	Completed
Phase
Start date	December 2013
Completion date	April 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01439503` - Safer Sex Program for Young African-American Men	Phase 2
Completed	`NCT00381992` - Risk Assessment of Long-Haul Truck Drivers	N/A
Completed	`NCT03294395` - New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea	Phase 3
Not yet recruiting	`NCT06428643` - A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities	N/A
Completed	`NCT03896776` - A Pragmatic Trial of Two Strategies for Implementing an Effective eHealth HIV Prevention Program (Keep It Up! 3.0)	N/A
Completed	`NCT03718806` - Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin	Phase 1
Completed	`NCT04010539` - A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea	Phase 3
Completed	`NCT00187902` - Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM	N/A
Completed	`NCT00262106` - Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection	Phase 3
Completed	`NCT00207506` - Lay Health Advisors for Sexually Transmitted Disease Prevention	Phase 1/Phase 2
Completed	`NCT04553068` - Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection	Phase 3
Active, not recruiting	`NCT03959527` - Zoliflodacin in Uncomplicated Gonorrhoea	Phase 3
Active, not recruiting	`NCT03980223` - Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men	Phase 4
Completed	`NCT01465607` - Implementation of an Efficacious Intervention for High Risk Women in Mexico	N/A
Terminated	`NCT00120770` - Cellulose Sulfate (CS) Gel and HIV in Nigeria	Phase 3
Completed	`NCT02391233` - Multimedia WORTH With Black Drug-Involved Women on Probation	N/A
Recruiting	`NCT05766904` - Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections	Phase 3
Completed	`NCT04297436` - Gonococcal Vaccine Study in Key Populations in Kenya	N/A
Completed	`NCT03098329` - Check it: A New Approach to Controlling Chlamydia Transmission in Young People	N/A
Completed	`NCT01836445` - Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men	N/A